IDH2 and glioma: In MSK_Impact, IDH1 alteration was 33% in various types of gliomas and 14% in hepatobiliary cancer (Figure 2D), whereas IDH2 mutation was seen most frequently in mature T and NK neoplasms (Figure 2E).